Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage.

Stroke

Hematology and Oncology Service, Centro Regional de Hemodonación, Universidad de Murcia, Spain.

Published: October 2004

AI Article Synopsis

  • Few genetic modifications have been linked to subarachnoid hemorrhage (SAH), primarily affecting aneurysm size and formation.
  • A study involving 103 SAH patients and 473 controls found that the HPA-1b allele offers protection against SAH while being associated with larger aneurysms but lower hemorrhage severity.
  • The presence of the HPA-1b allele may reduce SAH risk and severity, especially for smaller aneurysms, with an enhanced protective effect when combined with the HPA-2b allele.

Article Abstract

Background And Purpose: Few genetic modifications have been identified to be associated with subarachnoid hemorrhage (SAH), most of them playing a role in the formation or size of aneurysms.

Methods: We evaluated the role of common and functional polymorphisms affecting the main platelet adhesive glycoproteins (GP) (GPIIIa: HPA-1; GPIa: HPA-5 and C807T; GPIbalpha: HPA-2 and VNTR) in the risk for development of the disease and in the severity of the onset. The study was performed in 103 patients with SAH, 103 matched controls, and 473 subjects from the general population.

Results: The HPA-1b (PlA2) allele significantly protected against SAH (OR, 0.48; 95% CI, 0.24 to 0.96; P=0.037). Interestingly, patients carrying this allele displayed larger aneurysms, but the extension of their hemorrhage and the clinical grade at presentation was significantly lower when compared with patients HPA-1 a/a (11.9+/-2.8 mm versus 8.8+/-2.2 mm, P=0.0001. Fisher grade < or =2: 68.4% versus 20%; P=0.0001; Hunt and Hess score
Conclusions: We present the first evidence suggesting a protective role for the platelet GPIIIa HPA-1b allele in SAH. The suggested platelet hyper-reactivity determined by this allele could reduce the risk to suffer SAH, specially if the aneurysm is small, attenuate the severity of the hemorrhage, and reduce the clinical grade at presentation. This effect might be amplified by the simultaneous combination with the GPIbalpha HPA-2b allele.

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.STR.0000141978.33388.ebDOI Listing

Publication Analysis

Top Keywords

subarachnoid hemorrhage
8
platelet iiia
4
iiia polymorphism
4
polymorphism hpa-1
4
hpa-1 pla
4
pla protects
4
protects subarachnoid
4
hemorrhage background
4
background purpose
4
purpose genetic
4

Similar Publications

Background: Delayed cerebral ischemia (DCI) is a primary contributor to death after subarachnoid hemorrhage (SAH), with significant incidence. Therefore, early determination of the risk of DCI is an urgent need. Machine learning (ML) has received much attention in clinical practice.

View Article and Find Full Text PDF

Chitinase 3-like protein 1 (CHI3L1) is emerging as a promising biomarker for assessing intracranial lesion burden and predicting prognosis in traumatic brain injury (TBI) patients. Following experimental TBI, Chi3l1 transcripts were detected in reactive astrocytes located within the pericontusional cortex. However, the cellular sources of CHI3L1 in response to hemorrhagic contusions in human brain remain unidentified.

View Article and Find Full Text PDF

Subarachnoid hemorrhage (SAH) is a type of hemorrhagic stroke, and the neuroprotective effects of nimodipine following SAH have been well-documented. Sirtuin 3 (SIRT3), a mitochondrial nicotinamide adenine dinucleotide (NAD)-dependent deacetylase, plays a significant role in mitigating oxidative stress in various neurodegenerative conditions. However, the role of SIRT3 in the neuroprotective mechanisms of nimodipine after SAH remains unclear.

View Article and Find Full Text PDF

Background And Purpose: Experimental studies of subarachnoid hemorrhage (SAH) using the endovascular perforation model routinely use either cerebral blood flow (CBF) or intracranial pressure (ICP) monitoring to confirm SAH induction. We designed this study to test the hypothesis that contralateral CBF is a better marker of SAH induction than ipsilateral CBF.

Methods: Sixty-eight adult C57BL/6J mice were subjected to endovascular perforation.

View Article and Find Full Text PDF

Background: Delayed cerebral ischemia (DCI) is one of the most feared complications in aneurysmal subarachnoid hemorrhage (SAH). Animal models are crucial to studying the disease mechanisms and potential treatments. DCI in rodents was thought to not exist; herein we examine literature and our experience with DCI in rodents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!